Budget Impact Analysis of Biosimilar Infliximab Treatment for Rheumatoid Arthritis in Six Central European Countries
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1464
https://www.valueinhealthjournal.com/article/S1098-3015(13)03369-X/fulltext
Title :
Budget Impact Analysis of Biosimilar Infliximab Treatment for Rheumatoid Arthritis in Six Central European Countries
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03369-X&doi=10.1016/j.jval.2013.08.1464
First page :
A558
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1308